CA
ATRC icon

Continuum Advisory’s AtriCure ATRC Stock Holding History

Continuum Advisory’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24
Closed -$546 – 1931
2024
Q2 		$546 Hold
24
– – ﹤0.01% 1582
2024
Q1 		$528 Buy
+24
New +$804 ﹤0.01% 1595

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Continuum Advisory's ATRC Position: Q3 2024 in Review

Continuum Advisory sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 24 shares — an estimated $546 sold.

Continuum Advisory first reported a position in ATRC in Q1 2024 and held it in 2 quarters. The position peaked at $546 in Q2 2024. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

  • Continuum Advisory reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
  • Continuum Advisory sold 24 AtriCure shares in Q3 2024, an estimated $546.
  • Continuum Advisory first reported a position in AtriCure in Q1 2024 and held it in 2 quarters.
  • Continuum Advisory's AtriCure position peaked at $546 in Q2 2024.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Continuum Advisory's 13F filing for Q3 2024, filed 15 Nov 2024.